| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |